Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection

Journal of Infectious Diseases

Volumn 203, Issue 1, 2011, Pages 40-48

  Belser, Jessica A ^a   Zeng, Hui ^a   Katz, Jacqueline M ^a   Tumpey, Terrence M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE SEVERITY; HIGHLY PATHOGENIC AVIAN INFLUENZA H7; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; PRIORITY JOURNAL; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ADOLESCENT; ADULT; CELL DEATH; CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRULENCE; YOUNG ADULT;

EID: 79851488607     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq018     Document Type: Article

References (45)

1. Belser JA, Bridges CB, Katz JM, Tumpey TM. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis 2009; 15:859-65.
2. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11:201-9.
3. Fouchier RA, Schneeberger PM, Rozendaal FW, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004; 101:1356-61. (Pubitemid 38182693)
4. Centers for Disease Control and Prevention (CDC). Update: influenza activity-United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep 2004; 53:547-52.
5. Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004; 10:2196-9. (Pubitemid 39587346)
6. Dudley JP. Public health and epidemiological considerations for avian influenza risk mapping and risk assessment. Ecol Soc 2008; 13:21.
7. Belser JA, Blixt O, Chen LM, et al. Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility. Proc Natl Acad Sci U S A 2008; 105:7558-63. (Pubitemid 351830057)
8. Song H, Wan H, Araya Y, Perez DR. Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol J 2009; 6:126.
9. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-7. (Pubitemid 44527358)
10. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363:617-9. (Pubitemid 38264181)
11. Gao P, Watanabe S, Ito T, et al. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol 1999; 73:3184-9. (Pubitemid 29135710)
12. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 1999; 73:5903-11. (Pubitemid 29274877)
13. Maines TR, Lu XH, Erb SM, et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 2005; 79:11788-800.
14. Zitzow LA, Rowe T, Morken T, Shieh WJ, Zaki S, Katz JM. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol 2002; 76:4420-9. (Pubitemid 34309579)
15. de Wit E, Munster VJ, Spronken MI, et al. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol 2005; 79:12401-7. (Pubitemid 41346102)
16. Belser JA, Lu X, Maines TR, et al. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol 2007; 81:11139-47.
17. Joseph T, McAuliffe J, Lu B, Jin H, Kemble G, Subbarao K. Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J Virol 2007; 81:10558-66. (Pubitemid 47463329)
18. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6:135.
19. Hayman A, Comely S, Lackenby A, et al. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 2006; 347:52-64.
20. Zeng H, Goldsmith C, Thawatsupha P, et al. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J Virol 2007; 81:12439-12449. (Pubitemid 350085857)
21. Florea BI, Cassara ML, Junginger HE, Borchard G. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release 2003; 87:131-8. (Pubitemid 36255450)
22. Pekosz A, Newby C, Bose PS, Lutz A. Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures. Virology 2009; 386:61-7.
23. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831-7.
24. Chosewood LC, Wilson DE eds. Laboratory biosafety level criteria. Biosafety in microbiological and biomedical laboratories, 5th ed. Atlanta, GA: Centers for Disease Control and Prevention, 2009; 30-59.
25. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, Lau YL. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 2006; 194:61-70.
26. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998; 279:393-6. (Pubitemid 28063376)
27. Wolff T, Ludwig S. Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J Interferon Cytokine Res 2009; 29:549-57.
28. Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4:63-8.
29. Wang J, Oberley-Deegan R, Wang S, et al. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol 2009; 182:1296-304.
30. Balachandran S, Roberts PC, Kipperman T, et al. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol 2000; 74:1513-23. (Pubitemid 30044102)
31. Tanaka N, Sato M, Lamphier MS, et al. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 1998; 3:29-37. (Pubitemid 28374995)
32. Mibayashi M, Nakad K, Nagata K. Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol Immunol 2002; 46:29-36. (Pubitemid 34101084)
33. Numajiri A, Mibayashi M, Nagata K. Stimulus-dependent and domain-dependent cell death acceleration by an IFN-inducible protein, human MxA. J Interferon Cytokine Res 2006; 26:214-9. (Pubitemid 43668288)
34. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358:261-73.
35. Munster VJ, de Wit E, van Riel D, et al. The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 2007; 196:258-65. (Pubitemid 47047465)
36. de Wit E, Munster VJ, van Riel D, et al. Molecular determinants of adaptation of HPAI H7N7 viruses to efficient replication in the human host. J Virol 2010; 84(3);1597-606.
37. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008; 4:e1000115.
38. Osterlund P, Pirhonen J, Ikonen N, et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine response in human macrophages and dendritic cells and is highly sensitive to antiviral actions of interferons. J Virol 2010; 89(3);1414-22.
39. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202:8-32. (Pubitemid 39576902)
40. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 1994; 68:3667-73. (Pubitemid 24177391)
41. Marie I, Durbin JE, Levy DE. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998; 17:6660-9. (Pubitemid 28521799)
42. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730-7. (Pubitemid 39023305)
43. Veckman V, Osterlund P, Fagerlund R, Melen K, Matikainen S, Julkunen I. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006; 345:96-104. (Pubitemid 43107575)
44. Shinya K, Hamm S, Hatta M, Ito H, Ito T, Kawaoka Y. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 2004; 320:258-66. (Pubitemid 38315152)
45. Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007; 445:319-23.